London Daily

Focus on the big picture.
Monday, Aug 25, 2025

Baby gets go-ahead for world’s most expensive drug from NHS

Baby gets go-ahead for world’s most expensive drug from NHS

NHS approved to use gene therapy to treat baby born with spinal muscular atrophy
The parents of a baby with a fatal condition have succeeded in their campaign for their son to be treated with the world’s most expensive drug.

A new gene therapy, Zolgensma, will be used to treat 10-month-old Edward, from Colchester, who has severe spinal muscular atrophy (SMA), after his parents were given the green light earlier this week. The genetic condition, which is caused by a missing protein, weakens the muscles and affects movement and breathing.

About 65 babies are born with SMA in England each year, and most do not live past the age of two without intervention.

Edward’s mother, Megan Willis, who campaigned for her baby to be given the treatment, which costs £1.79m per patient, told the Guardian she was “thankful and ecstatic” to get the news on Wednesday.

“I’m exhausted. It’s been such a long ride and a rollercoaster,” the 29-year-old said. “When I think back to myself in November, newly diagnosed, I didn’t think there was an option for him – I thought he was dying because that’s that all it said when I read up on SMA, that 95% of children die, or are severely disabled. I didn’t think he had a future.”

The drug contains a copy of the missing gene SMN1, allowing it to halt the condition’s progression. Willis said that after learning about the treatment, the family had a “glimmer of hope” but felt crushed when they learned the extortionate cost of the treatment. After “countless sleepless” night she felt hugely relieved to get the news that the NHS would treat Edward by the middle of August.

As the drug is far more effective when administered at a young age, “time is massively of the essence”, Willis said. “Zolgensma just transforms a baby – it just really does. Children are walking, talking, eating, standing. It’s incredible.”

Edward, who was diagnosed at two months, is currently being treated with Spinraza, which is administered by injection every four months. Unlike the one-off injection of Zolgensma, it is a treatment carried out for life.

Zolgensma was approved for use by the NHS in March, but guidelines set by the National Institute for Health and Care Excellence said it should only be used for babies under six months old who were not already being treated. However, it added a decision on whether to give it to other babies, including those who like Edward were already receiving other treatment, would be dealt with on a case-by-case basis.

“We are so lucky,” Willis said. “Edward has a future whereas so many children before him didn’t have options. We’re in a new age of SMA. The fact that it is an option to our children is a blessing.”
Newsletter

Related Articles

0:00
0:00
Close
Vietnam Evacuates Hundreds of Thousands as Typhoon Kajiki Strikes; China’s Sanya Shuts Down
UK Government Delays Decision on China’s Proposed London Embassy Amid Concerns Over Redacted Plans
A 150-Year Tradition to Be Abolished? Uproar Over the Popular Central Park Attraction
A new faith called Robotheism claims artificial intelligence isn’t just smart but actually God itself
Deputy Prime Minister Angela Rayner Purchases Third Property Amid Housing Tax Reforms Debate
HSBC Switzerland Ends Relationships with Over 1,000 Clients from Saudi Arabia, Lebanon, Qatar, and Egypt
Sharia Law Made Legally Binding in Austria Despite Warnings Over 'Incompatible' Values
Italian Facebook Group Sharing Intimate Images Without Consent Shut Down Amid Police Investigation
Dutch Foreign Minister Resigns Amid Deadlock Over Israel Sanctions
Trump and Allies Send Messages of Support to Ukraine on Independence Day Amid Ongoing Conflict
China Reels as Telegram Chat Group Shares Hidden-Camera Footage of Women and Children
Sam Nicoresti becomes first transgender comedian to win Edinburgh Comedy Award
Builders uncover historic human remains in Lancashire house renovation
Australia Wants to Tax Your Empty Bedrooms
MotoGP Cameraman Narrowly Avoids Pedro Acosta Crash at Hungarian Grand Prix
FBI Investigates John Bolton Over Classified Documents in High-Profile Raids
Report reveals OpenAI pitched national ChatGPT Plus subscription to UK ministers
Labour set to freeze income tax thresholds in long-term 'stealth' tax raid
Coca‑Cola explores sale of Costa coffee chain
Trial hears dog walker was chased and fatally stabbed by trio
Restaurateur resigns from government hospitality council over tax criticism
Spanish City funfair shut after serious ride injury
Suspected arson at Ilford restaurant leaves three in critical condition
Tottenham beat Manchester City to go top of Premier League
Bank holiday heatwave to hit 30°C before remnants of Hurricane Erin arrive
UK to deploy immigration advisers to West Africa to block fake visas
Nurse who raped woman continued working for a year despite police alert
Drought forces closures of England’s canal routes, canceling boat holidays
Sweet tooth scents: food-inspired perfumes surge as weight-loss drugs suppress appetites
Experts warn Britain dangerously reliant on imported food
Family of Notting Hill Carnival murder victim call event unmanageable
Bunkers, Billions and Apocalypse: The Secret Compounds of Zuckerberg and the Tech Giants
Ukraine Declares De Facto War on Hungary and Slovakia with Terror Drone Strikes on Their Gas Lifeline
Animated K-pop Musical ‘KPop Demon Hunters’ Becomes Netflix’s Most-Watched Original Animated Film
New York Appeals Court Voids Nearly $500 Million Civil Fraud Penalty Against Trump While Upholding Fraud Liability
Elon Musk tweeted, “Europe is dying”
Far-Right Activist Convicted of Incitement Changes Gender and Demands: "Send Me to a Women’s Prison" | The Storm in Germany
Hungary Criticizes Ukraine: "Violating Our Sovereignty"
Will this be the first country to return to negative interest rates?
Child-free hotels spark controversy
North Korea is where this 95-year-old wants to die. South Korea won’t let him go. Is this our ally or a human rights enemy?
Hong Kong Launches Regulatory Regime and Trials for HKD-Backed Stablecoins
China rehearses September 3 Victory Day parade as imagery points to ‘loyal wingman’ FH-97 family presence
Trump Called Viktor Orbán: "Why Are You Using the Veto"
Horror in the Skies: Plane Engine Exploded, Passengers Sent Farewell Messages
MSNBC Rebrands as MS NOW Amid Comcast’s Cable Spin-Off
AI in Policing: Draft One Helps Speed Up Reports but Raises Legal and Ethical Concerns
Shame in Norway: Crown Princess’s Son Accused of Four Rapes
Apple Begins Simultaneous iPhone 17 Production in India and China
A Robot to Give Birth: The Chinese Announcement That Shakes the World
×